About Topera
Topera is a Healthcare company based in Menlo Park (United States) founded in 2010, and was acquired by Abbott in October 2014. It operates as a catheter-based electrophysiology mapping for atrial fibrillation treatment is offered. Topera has raised $31.52 million across 3 funding rounds from investors including Abbott and NEA. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, In-Vitro Diagnostics and Arrhythmia. Its competitors include Wearlinq, CoreMap, Cardinor, Bionet and Koshihikari and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Founded in 2010, Topera operates in the medical device sector, focusing on electrophysiology tools for cardiac arrhythmias. A 3D analysis and mapping system, including the FDA-approved RhythmView Workstation and FIRMap diagnostic catheter, is utilized to visualize heart electrical activity. Diagnosis and treatment planning for conditions such as atrial fibrillation, flutter, tachycardia, and ventricular tachycardia are supported from operations in Menlo Park, United States.
- Headquarters Menlo Park, United States
- Stage Acquired
- SectorsHealthcare
- Website toperamedical.com
- Social LinkedIn X
- Acquired by Abbott (Oct 2014)
Funding Insights of Topera
Topera has successfully raised a total of $31.52M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in March 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31.52M
- Total Rounds 3
- Last Round Series C — $25M
- First Round $2.75M
(May 2012)
- Investors Count 1
All 3 funding rounds of Topera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2013 | $25M | Series C | – | – | |
| Oct 2012 | $3.77M | Series A | – | – | – |
| May 2012 | $2.75M | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Topera
Topera has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Abbott and NEA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are offered to startups by NEA. | – | nea.com | Menlo Park, United States | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | abbott.com | Libertyville, United States |
Investor details for Topera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Topera
4 dated milestones of Topera across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Topera is founded.
- Funding First funding round of $2.7M.
- Funding Latest funding round, Series C, of $25.0M.
- Exit Acquired by Abbott.
Competitors of Topera
Topera has 9 listed competitors in our database, 3 of them funded. They include Wearlinq, CoreMap, Cardinor, Bionet and Koshihikari, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wearlinq.com | 2019 | Stanford, United States | $12.28M | – | A wearable ECG device is provided for heart disorder detection. | |
| coremapmedical.com | 2017 | Burlington, United States | $31.3M | – | Atrial fibrillation detection platform is provided for heart disorder management. | |
| cardinor.com | 2015 | Oslo, Norway | $921,842 | 2 | Biomarker-based assays for cardiovascular diseases are developed and provided. | |
| babybanks.com | 1999 | Taipei, Taiwan | – | – | Cord blood banking service provider along with services on genetic testing | |
| prudencemed.com | 2013 | China | – | – | AI-based ECG diagnostic systems for cardiovascular disease detection are provided. | |
| auscultechdx.com | 2013 | Bethesda, United States | – | – | Computer-aided auscultation tools for pediatric heart murmurs are developed. | |
| wegene.com.tw | 2000 | Taipei, Taiwan | – | – | Wireless ECG & autonomic nerve analyzer for cardiac diagnostics | |
| getsmartheart.com | 2011 | Easthampton, United States | – | – | Portable EKG device for home-based cardiac monitoring and early detection of issues. | |
| deltavital.eu | 2014 | Gothenburg, Sweden | – | – | Develops novel risk markers for detecting arrhythmia in patients. |
Detailed competitors of Topera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Topera (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Topera
Complete news archive for Topera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Topera
Topera was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Topera is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Topera is a funded company, having raised a total of $31.52M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.75M, raised on May 2012.
Founded in 2010, Topera operates in the medical device sector, focusing on electrophysiology tools for cardiac arrhythmias. A 3D analysis and mapping system, including the FDA-approved RhythmView Workstation and FIRMap diagnostic catheter, is utilized to visualize heart electrical activity. Diagnosis and treatment planning for conditions such as atrial fibrillation, flutter, tachycardia, and ventricular tachycardia are supported from operations in Menlo Park, United States.
Yes. Topera was acquired by Abbott in October 2014.